INTRODUCTION
The dopamine system plays an important role in the modulation of a large number of neuronal functions, including movement, drive and reward, and alterations of dopamine (Seeman and Van Tol, 1994) . Like all G-protein linked receptors, the affinity of D 2 -like receptors for agonists is affected by the coupling of the receptors with G proteins. The high affinity sites (D 2high ) are G protein-coupled, while the low affinity sites (D 2low ) are those uncoupled with G protein. In vitro homogenate binding studies suggest that approximately 50% of D 2 receptors are configured in the D 2high state (Sibley et al., 1982) . However, very little is known about the proportion of D 2 receptors that are configured in D 2 high state (%R high ) in vivo.
Over the years, antagonists and inverse agonists such as [ 11 C]raclopride and [ 11 C]Nmethyl-spiperone have been developed as radiotracers for imaging D 2 -like receptors using positron emission tomography (PET). As these antagonists and inverse agonists binds with equal affinity to both D 2 high and D 2 low receptors, or tends to preferentially bind to the D 2 low , they cannot provide information about the D 2 high receptors (Roberts and Strange, 2005) .
(-)-N-Propyl-norapomorphine (NPA) is a full agonist at the D 2 and D 3 receptors (Neumeyer et al., 1973; Gardner and Strange, 1998) . The in vitro affinity of NPA for D 2high and D 2low sites have been reported to be in the range of 0.07 to 0.4 nM and 20 to 200 nM respectively, suggesting a 50 to 200 fold selectivity for D 2high compared to D 2 low sites (for references see Table 1 ).
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JPET Fast Forward. Published on July 12, 2005 as DOI: 10.1124 at ASPET Journals on July 12, 2017 jpet.aspetjournals.org Downloaded from Hwang et al. (2000) reported a procedure to radiolabel NPA with C-11, as well as initial imaging experiments in baboons using [ 11 C]NPA. In baboons, [ 11 C]NPA demonstrated a rapid brain uptake with selective accumulation in the striatum. The striatal uptake was decreased to the level of cerebellar uptake following pretreatment with the D 2 receptor antagonist haloperidol, indicating that the striatal uptake of [ 11 C]NPA was saturable and selective for D 2 -like receptors.
Furthermore, the uptake kinetics of [ 11 C]NPA were fast and amenable to quantitative analysis.
In baboons, the binding potential (BP) of [ 11 C]NPA in the striatum was reported as 4.04 ± 1.05 mL g -1 .
Under tracer conditions, the BP of a radiotracer is proportional to the product of the site density (B max ) and affinity (1/K D ),
where f 1 is the free fraction of the ligand in plasma. from which it appears that the contribution of BP low to BP NPA is likely to be small. For example, if we assume based on in vitro homogenate binding studies that in vivo 20-50% of the sites are configured in R high and use the values reported by (Gardner and Strange, 1998) in Table   1 for K high and K low , the contribution of BP low to BP NPA would be approximately 9.6-2.3%. et al., 1994a; Laruelle et al., 1994b) . Data were analyzed using three methods: simple equilibrium analysis (based on the analysis of the data during the equilibrium interval), kinetic analysis (based on the arterial input function), and a mixed method, denoted modeled equilibrium analysis, with peak equilibrium values estimated from the kinetic fit of the data (Slifstein et al., 2004b) .
METHODS

General Design
A total of 12 PET scans were acquired in 3 male baboons (Papio anubis, 25, 20 Narendran et al., 2004) . The specific activity of the radioligand was controlled such that the targeted levels of receptor occupancy at steady-state would be less than 5% and about 60-70% for the NCA and CA experiments, respectively. For each animal, the sequence of radiotracers was counterbalanced to prevent bias in the between-radiotracer comparison.
Synthesis of [ 11 C]raclopride and [ 11 C]NPA
endotracheal tube. Vital signs were monitored every 10 min and temperature was kept constant at 37 o C with heated water blankets. An I.V. perfusion line was used for the injection of radiotracers and a catheter inserted in a femoral artery was used for arterial blood sampling.
PET imaging was performed with ECAT EXACT HR+ scanner (Siemens/CTI, Knoxville, TN). Following a 10-min transmission scan, emission data was collected in 3D mode for 90 min as successive frames (21 frames) of increasing duration for both [ 11 C]raclopride and
Input function measurements
A total of 30 arterial samples were collected per experiment with an automated blood sampling system for the first four minutes followed by manual draws at various intervals.
Following centrifugation (10 min at 1800g), plasma was collected and activity measured in 0.2 mL aliquots on a gamma counter (Wallac 1480 Wizard 3M Automatic Gamma Counter, PerkinElmer, Boston, MA). and 80 min), six samples were further processed using previously described HPLC procedures (Mawlawi et al., 2001; Hwang et al., 2004) to measure the fraction of plasma activity representing unmetabolized parent compound. The parent fraction was calculated as the ratio of parent to total activity. The parent fractions were fitted to the sum of two exponentials. The smallest exponential of the fraction of the parent curve, λ par , was constrained to the difference between λ cer (the terminal rate of washout of the cerebellar activity) and λ tot (the smallest elimination rate constant of the total plasma) (Abi-Dargham et al., 1999 ). The input function was then calculated as the product of the total counts and the interpolated fraction parent at each time point.
The measured input function values (C a (t), µCi mL -1 ) were fitted to 
where C 0 i is the zero time intercept of each exponential (nM), λ 1 is the elimination rate constant (min -1 ) associated with each exponential, f 0i is the fraction of zero time intercept associated with each exponential, and C SS the free concentration at steady state (nM). The first term of equation (Eq 3) represents activity due to the bolus and the second term the activity due to the constant infusion. C SS is related to clearance (C L , L h -1 ) and the rate of infusion R o (nmol h -1 ), by
The plasma free fraction (f 1 ) was measured by ultrafiltration for both tracers using techniques described previously .
Image Analysis
The striatum and cerebellum ROIs (regions of interest) were delineated on each baboon's brain MRI (a T1-weighted axial MRI sequence, acquired parallel to the anterior-posterior commissure, TR 34 msec, TE 5 msec, flip angle of 45 degrees, slice thickness 1.5 mm, zero gap, matrix 1.5 mm x 1 mm x 1mm voxels).
Attenuation-corrected PET emission data were reconstructed with filtered backprojection, using a Shepp filter (cutoff 0.5 cycles/projection rays) and processed using the image analysis software MEDx (Sensor Systems, Inc., Sterling, Virginia). An image was created by summing all the frames, and this summed image was used to define the registration parameters for use with the MRI, using the between-modality automated image registration (AIR) algorithm, as described previously (Mawlawi et al., 2001) . Registration parameters were then applied to the individual frames for registration to the MRI data set. Regional boundaries were transferred to the individual registered PET frames, and time-activity curves were measured. Right and left striata were averaged. For a given animal, the same regional boundaries were used for both the NCA and CA experiments.
Derivation of outcome measures
Distribution volumes
The regional tissue distribution volume (V T , mL g -1 ) was defined as the ratio of the ligand concentration in a region (A T , µCi mL -1 ) to the concentration of unmetabolized ligand in arterial plasma (C SS , µCi mL -1 ) at equilibrium
As the concentration of D 2 receptors is negligible in the cerebellum (Mawlawi et al., 2001) , only free and nonspecifically bound radiotracer were considered to contribute to V T in the cerebellum (V T CER ), and V T CER was assumed to be equal to the nondisplaceable distribution volume (V 2 ). The striatal V T (V T STR ) included V 2 and the specific binding distribution volume (V 3 ). It was assumed that the nondisplaceable distribution volume was equal in both regions.
Therefore, V 3 was derived as V T STR minus V T CER .
Binding parameters
The primary parameters of interest in this study were B max , the concentration of sites (nanomoles per L of tissue, nM), and K D , the in vivo equilibrium dissociation constant of the radiotracer (nanomoles per L of brain water, nM). Secondary parameters included the binding potential (BP, ml g -1 ) and the specific to nonspecific partition coefficient (V3", unitless). BP and V 3 " are related to B max and K D by
where f 1 and f 2 are the free fractions in the plasma and the nondisplaceable compartment, respectively. BP and V 3 " were derived only in NCA experiments.
Derivation of B max and K D were determined by three analytical methods.
Method A. Simple equilibrium analysis
Equilibrium analysis was applied to the PET frames obtained from 40-90 minutes. The slope of the cerebellum and striatum activity over time expressed as a percentage of the mean value obtained from 40-90 minutes was used as a measure of the degree of equilibrium attained.
The activity (µCi mL -1 ) in the cerebellum (A CER ) and striatum (A STR ) were averaged from 40-90 minutes. V T CER was derived as
At equilibrium, the free tracer equilibrates across the blood-brain barrier so that the intracerebral free ligand concentration Fe (nM) is equal to the free ligand concentration in plasma
At equilibrium, the bound ligand concentration B e (nM), was derived as
For each animal with each ligand, B e and F e data obtained from the NCA and CA experiments were fitted to the Scatchard plot equation (Scatchard, 1949 ) In the 1TCM, V T was derived from kinetic parameters as
In the 2TCM, V T was derived from kinetic parameters as
Kinetic rate constants were estimated by nonlinear regression using a LevenbergMarquardt least-squares minimization procedure implemented in MATLAB (Math Works). BP and V 3 " were derived as described above.
Analysis of CA experiments. Data were fitted to the following nonlinear system of differential equations (Sadzot et al., 1991; Slifstein et al., 2004a )
Eq. 14
where C a , C 2 and C 3 are the concentration in the arterial, nondisplaceable, and specific compartments, respectively and k + = f 2 k on . K D and B max were determined as This article has not been copyedited and formatted. The final version may differ from this version. 
All the parameters (other than f 2 which was derived as
) were estimated by nonlinear least squares regression of the data onto the numerical solution of the differential equations with two constraints as previously described (Slifstein et al., 2004b) : 1) the ratio K 1 /k 2 in each experiment was constrained to V T CER as estimated in that experiment; 2) the total regional distribution volume, K 1 /k 2 *(1+ k 3 /k 4 ), was constrained to the V T STR measured in NCA experiments. All kinetic analysis was performed in the Matlab (Mathworks, Natuck MA) software environment.
Method C. Modeled equilibrium analysis
The modeled equilibrium method was adapted from peak equilibrium analysis (Farde et al., 1986 ) and modified as previously described (Slifstein et al., 2004b) . Data from each experiment were fitted by kinetic modeling as described above to yield modeled specifically bound and free plus nonspecifically bound curves. B e was determined as the peak of the specifically bound curve. F e was determined as f 2 times the value of the free plus nonspecifically bound curve at the time of peak specific binding. In other words bound and free were both estimated from the values of these parameters that were determined from the kinetic fit within the region of interest itself and not from the difference between the region of interest and the reference region. As the f 2 used in method C was obtained from the same kinetic fit outlined in method B these methods were not truly independent of each other. For all 3 animals, data were fitted to the Scatchard plot equation (Eq. 11) and K D and B max were determined as described above.
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Statistical analysis
Statistical analysis was performed with paired t tests to test differences between conditions (NCA and CA) unless otherwise specified. A two tailed probability value of p < 0.05 was selected as significant.
RESULTS
Injected dose and mass
The mean injected dose for [ 11 C]raclopride was 2.07 ± 0.56 mCi and 4.03 ± 1.45 mCi for the NCA (n=3) and CA (n=3) conditions, respectively. The mean injected mass for [ 11 C]raclopride was 1.05 ± 0.15 µg (3.0 ± 0.4 nmoles) and 336 ± 87 µg (969 ± 250 nmoles) for the NCA and CA conditions respectively.
The mean injected dose for [ 11 C]NPA was 2.96 ± 1.25 mCi and 3.60 ± 0.65 for the NCA (n=3) and CA (n=3) conditions respectively. The mean injected mass for [ 11 C]NPA was 1.24 ± 0.19 µg (4.2 ± 0.6 nmoles) and 180 ± 7 µg (611 ± 22 nmoles) for the NCA and CA conditions respectively. Table 2 lists the plasma clearance, f 1 , and C SS for the NCA and CA conditions for both cerebellum. For [ 11 C]raclopride, changes over this interval were -2 ± 5%/h in the striatum and -8
Plasma parameters
± 5%/h in the cerebellum. For [ 11 C]NPA, these changes were -1 ± 10%/h and -3 ± 10%/h in striatum and cerebellum.
Binding parameters
Method A. Simple equilibrium analysis in all three baboons with the simple equilibrium analysis (see Figure 4) .
Method B. Kinetic analysis
The mean kinetic V 2 for [ 11 C]raclopride was 0.91 ± 0.34 mL g -1 and 0.75 ± 0.27 mL g -1 for the NCA (n=3) and CA (n=3) conditions respectively (paired t test, p = 0.15). The mean kinetic BP and V 3 " was 2.53 ± 1.25 mL g -1 and 2.71 ± 0.36 for the [ 11 C]raclopride NCA condition.
The mean kinetic V 2 for [ 11 C]NPA was 6.30 ± 0.56 mL g -1 and 5.40 ± 1.03 mL g -1 for the NCA (n=3) and CA (n=3) conditions respectively (paired t test, p = 0.38). The mean kinetic BP and V 3 " was 6.08 ± 2.45 mL g -1 and 0.96 ± 0.33 for the [ 11 C]NPA NCA condition. 
DISCUSSION
The two main findings of this study are 1) the in vivo affinity of [ 11 C]NPA is 0.16 nM and 2) the number of binding sites available to [ 11 C]NPA at this affinity is 21.6 ± 2.8 nM,
corresponding to 79% ± 2% of the sites available to [ 11 C]raclopride (27.3 ± 3.9 nM). The technical strengths and weaknesses of the study design and the implications of these findings are discussed.
Agreement between the methods
In this study, K D and B max were derived using three methods. The simple equilibrium analysis requires the establishment of a sustained equilibrium state. As [ 11 C]raclopride and [ 11 C]NPA both have relatively fast kinetics, they achieved reasonable and comparable equilibria within the duration of the study. The agreement in the derivation of B max and K D between the kinetic analysis, which does not require attainment of equilibrium during the scan, and simple equilibrium analysis acted as an internal control. The agreement between these methods was strengthened by the modeled equilibrium analysis that integrates elements of each.
Opposite effects of raclopride and NPA on endogenous dopamine
The acute administration of D 2 antagonists and D 2 agonists at pharmacological doses during the CA condition induces an increase or decrease of dopamine concentration relative to that under tracer conditions (Bunney et al., 1973a; Bunney et al., 1973b) . As this change in endogenous dopamine could present a source of potential artifact, the effect of such changes on This article has not been copyedited and formatted. The final version may differ from this version. 
Effects of anesthesia on fraction of R high.
Another potential confound for this study is the effect of anesthesia (isoflurane and ketamine) on the binding parameters of both radiotracers. In vitro homogenate binding studies using anesthetic doses of ketamine and isoflurane have been shown to inhibit the high affinity state of D 2 receptors (Seeman and Kapur, 2003 Table 5 ) reported to be in the 1 to 2 nM range. In contrast, the [ 11 C]raclopride in vivo K D reported in this study is lower than in vivo values reported using PET (Table 6) , which range between 8 and 12 nM. As previously noted (Laruelle et al., 1994b) this discrepancy results from the use of total cerebellum activity to represent free ligand in the previous PET studies. Taking into account that only 14.6% ± 2.1% of the cerebellum concentration is free (f 2 , 
[ 11 C]NPA binding parameters
In vitro, the binding of NPA to D 2 receptors is best fitted by a two site model (Table 1) , and the high affinity state is converted to low affinity state in the presence of GTP . In this study, the two-point scatchard plots of [ 11 C]NPA fitted to a one-site model estimated an affinity of 0.16 ± 0.01 nM, values that are consistent with the affinity of NPA for D 2 high measured in vitro ( ) and the likely 100 fold difference between the K high and K low (Sibley et al., 1982) this procedure would be problematic. This is because the inflection of the curve due to low affinity site binding would only become apparent at saturation levels greater than 80%, where the signal to noise ratio of PET is too low to provide useful data (see simulation in Figure   This article has not been copyedited and formatted. The final version may differ from this version. . Three male baboons were studied with , 1997) , the results of that study predicted the % R high to be 79% (see Figure 7 in Narendran et al., 2004) , consistent with the direct measurement of % R high in the current study (79% ± 2%).
This result is also consistent with a recent PET study conducted in rhesus monkey by Kortekaas et al (2004) . The results of this study are also consistent with an in vitro study measuring D 2 high and D 2 low with autoradiography (Richfield et al., 1989) , a setting in which endogenous receptor coupling is more likely to be preserved than in homogenates (where %R high has been reported in the range of 12-50% (Sibley et al., 1982; Seeman et al., 2002) ). Competition studies of This article has not been copyedited and formatted. The final version may differ from this version. We examine the effect on K D determined by 2 point Scatchard plot when the high occupancy dose has pharmacological effects. We look at 2 cases -increased extracellular endogenous neurotransmitter during the high mass dose (antagonist) and decreased endogenous neurotransmitter (agonist) during the high mass dose. In each case we assume that there is baseline occupancy by endogenous transmitter, so that the reference value is not K D , but K D ' = K D (1 + R) where R is the baseline ratio of the extracellular concentration of endogenous ligand to its inhibition constant.
Case 1: Antagonist
In this case the equilibrium equations for the low mass and high mass doses are
where B L , F L , B H and F H are bound and free radiotracer under low and high mass dose conditions, K D ' is as described above, and γ = R 2 /(1+R 1 ) where R 2 is the increase in the ratio R following the high mass dose.
By dividing these expressions by F to obtain B/F and rearranging to obtain the slope (
where the factor f is the expression in parentheses.
Case 2: Agonist
For clarity we make the simplifying assumption that, following the high mass dose, the extracellular concentration of endogenous neurotransmitter is 0. In this case, the conditions are where f refers to the factor by which KD' is changed, as described in the 2 cases above. For the present case, where there are 2 points (high and low mass), both points are on the regression line, so these equations are an identity; either the low or high mass observed values can be substituted into the equation and equality will be preserved.
When the low mass values are substituted into the equation, the formula is the same for both the agonist and antagonist cases, although the meaning of the factor f is different in the two cases, as above. The result is i.e. the Bmax estimate will be altered in the same direction and to approximately the same extent as the affinity estimate. This result has the intuitive interpretation that if the low mass scan is performed under truly tracer dose conditions, then the datum (B L , B L /F L ) will be very close to the y axis, so that rotations of a line about this point will cause little change in the y axis intercept, i.e. true binding potential (B max /K D without reference to any free fraction) will be nearly preserved. Since the ratio of the two factors remains relatively unchanged, the factors themselves will be altered to the same extent.
